Valerie-ann Raymond
Montreal, QC H2X0A9, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Glutaminase Reprogramming in Hepatocellular Carcinoma: Implications for Diagnosis, Prognosis, and Potential as a Novel Therapeutic Target.
Journal: International journal of molecular sciences
Published: August 19, 2025
Reprogramming of Glutamine Amino Acid Transporters Expression and Prognostic Significance in Hepatocellular Carcinoma.
Journal: International journal of molecular sciences
Published: June 05, 2024
Metabolomics-Guided Identification of a Distinctive Hepatocellular Carcinoma Signature.
Journal: Cancers
Published: April 27, 2023
MYC Rules: Leading Glutamine Metabolism toward a Distinct Cancer Cell Phenotype.
Journal: Cancers
Published: August 06, 2021
Oxaloacetate Protects Rat Liver From Experimental Warm Ischemia/Reperfusion Injury by Improving Cellular Energy Metabolism.
Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Published: August 03, 2018
Upregulation of Krebs cycle and anaerobic glycolysis activity early after onset of liver ischemia.
Journal: PloS one
Published: April 17, 2018
Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment.
Journal: Cell cycle (Georgetown, Tex.)
Published: April 11, 2018
Metabolite profiling identifies a signature of tumorigenicity in hepatocellular carcinoma.
Journal: Oncotarget
Published: March 26, 2018
Highly tumorigenic hepatocellular carcinoma cell line with cancer stem cell-like properties.
Journal: PloS one
Published: November 04, 2016
Last Updated: 09/26/2026